Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States.
- DOI
- 10.1007/s10549-026-08011-6
- Published
- 2026-08-12
- Container
- Breast Cancer Res Treat
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-026-08011-6,
title = {Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States.},
author = {Lynce F and Ru M and Luo L and Miranda M and Xu X and Isaacs C.},
year = {2026},
journal = {Breast Cancer Res Treat},
doi = {10.1007/s10549-026-08011-6},
url = {https://doi.org/10.1007/s10549-026-08011-6}
}RIS
TY - JOUR TI - Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States. AU - Lynce F AU - Ru M AU - Luo L AU - Miranda M AU - Xu X AU - Isaacs C. PY - 2026 JO - Breast Cancer Res Treat DO - 10.1007/s10549-026-08011-6 UR - https://doi.org/10.1007/s10549-026-08011-6 ER -
APA
F, L., M, R., L, L., M, M., X, X., & C., I. (2026). Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States.. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-026-08011-6
Source records
- europe-pmc · retrieved 2026-09-26T12:54:33.433Z